Clene Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Clene Inc. (CLNN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.89 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-17
- Clene Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $4.97M.
- Clene Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $1.89M, a 61.89% decline from fiscal 2023.
- Clene Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $4.97M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2024-12-31 | $1.89M 10-K · filed 2026-03-17 | |
| 2023-12-31 | $4.97M 10-K · filed 2025-03-24 | |
| 2023-06-30 | $4.97M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |